1. Home
  2. ACIU vs PAMT Comparison

ACIU vs PAMT Comparison

Compare ACIU & PAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$2.51

Market Cap

247.6M

Sector

Health Care

ML Signal

HOLD

Logo PAMT CORP

PAMT

PAMT CORP

HOLD

Current Price

$11.64

Market Cap

275.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACIU
PAMT
Founded
2003
1980
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
247.6M
275.4M
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
ACIU
PAMT
Price
$2.51
$11.64
Analyst Decision
Strong Buy
Hold
Analyst Count
2
1
Target Price
$10.00
★ $13.00
AVG Volume (30 Days)
★ 138.7K
14.1K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $437,838,000.00
Revenue This Year
$706.75
$20.12
Revenue Next Year
$321.13
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 1.15
52 Week Low
$2.10
$7.15
52 Week High
$4.00
$17.75

Technical Indicators

Market Signals
Indicator
ACIU
PAMT
Relative Strength Index (RSI) 41.53 41.04
Support Level $2.13 $10.69
Resistance Level $2.68 $13.04
Average True Range (ATR) 0.13 0.84
MACD -0.03 -0.04
Stochastic Oscillator 10.55 24.43

Price Performance

Historical Comparison
ACIU
PAMT

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About PAMT PAMT CORP

PAMT Corp is a holding company that is engaged in providing truckload dry van carrier services transporting general commodities throughout the continental United States and Mexico, as well as in certain Canadian provinces. Its freight consists of automotive parts, expedited goods, consumer goods, such as general retail store merchandise, and manufactured goods, such as heating and air conditioning units. It has one reportable segment being motor carrier.

Share on Social Networks: